REGISTERED
on 13 Nov 2018
Last Applicant/ Owned by
4761 Tara Court
W. bloomfield
MI
48323
Serial Number
87832569 filed on 13th Mar 2018
Registration Number
5605676 registered on 13th Nov 2018
Correspondent Address
Timothy C. Bradley
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
PURE SLEEP
Polyvinyl alcohol soluble films for use in the manufacture of delivery agents for pharmaceuticals, breath freshener, vitamins, and candy Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical preparati Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention of insomnia; Pharmaceutical preparations for the treatment and prevention of insomnia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of insomnia; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, elixirs for the treatment of insomnia; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals, namely, psychotropics; Analeptics; Anti-epileptic pharmaceutical preparations; Balms for pharmaceutical purposes; Bandages impregnated with sleep medication; Chemical preparations for pharmaceutical or medical purposes, namely, for sleep; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of sleep agents that facilitate the delivery of pharmaceutical preparations; Plant extracts for medical, veterinary and pharmaceutical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Therapeutic pharmaceutical for the treatment of insomnia; Unit dose capsules sold empty for pharmaceutical use; Veterinary pharmaceutical preparations for the prevention of insomnia; Veterinary pharmaceutical preparations for the treatment of insomnia
First Use Date in General
01st Feb 2018
First Use Date in Commerce
01st Feb 2018
Class [001]
Chemical Products
Polyvinyl alcohol soluble films for use in the manufacture of delivery agents for pharmaceuticals, breath freshener, vitamins, and candy
First Use Date in General
01st Feb 2018
First Use Date in Commerce
01st Feb 2018
Mark Details
Serial Number
No 87832569
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 68007-003 T1
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Nov 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 13th Nov 2018 | REGISTERED-PRINCIPAL REGISTER |
| 28th Aug 2018 | PUBLISHED FOR OPPOSITION |
| 28th Aug 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 08th Aug 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 15th Jul 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 27th Jun 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 26th Jun 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 26th Jun 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 25th Jun 2018 | NON-FINAL ACTION WRITTEN |